NextCure (NXTC) Other Working Capital Changes (2023 - 2026)
NextCure (NXTC) posted quarterly Other Working Capital Changes of -$36000.0 for Q1 2026, up 85.0% year-over-year from -$19459.5 in Q1 2025, and up 96.02% quarter-over-quarter from -$905000.0 in Q4 2025.
NextCure (NXTC) Other Working Capital Changes (2023 - 2026) Analysis & Trends
NextCure's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$36000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 85.0% year-over-year to -$36000.0; the TTM figure through Mar 2026 stood at -$801000.0 (down 139.82% YoY), while the FY2025 annual figure was -$1.0 million, down 710.48% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$36000.0, up from -$905000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.1 million in Q1 2024, with the low at -$2.5 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is -$446000.0 (2024), against an average of -$392176.5.
- Peak annual rise in Other Working Capital Changes reached 177.45% in 2025, while the deepest fall reached 726.67% in 2025.
- NextCure's Other Working Capital Changes stood at $371000.0 in 2023, then grew by 17.79% to $437000.0 in 2024, then tumbled by 307.09% to -$905000.0 in 2025, then jumped by 96.02% to -$36000.0 in 2026.
- Business Quant data shows NXTC's Other Working Capital Changes at -$36000.0 in Q1 2026, -$905000.0 in Q4 2025, and $388000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -276,000.00 |
| Jun 30, 2026 | -276,000.00 |
| Jun 30, 2026 | -276,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Mar 31, 2026 | -36,000.00 |
| Dec 31, 2025 | -905,000.00 |
| Dec 31, 2025 | -905,000.00 |
| Dec 31, 2025 | -905,000.00 |
| Sep 30, 2025 | 388,000.00 |
| Sep 30, 2025 | 388,000.00 |
| Sep 30, 2025 | 388,000.00 |
| Jun 30, 2025 | -248,000.00 |
| Jun 30, 2025 | -248,000.00 |
| Jun 30, 2025 | -248,000.00 |
| Mar 31, 2025 | -240,000.00 |
| Mar 31, 2025 | -240,000.00 |
| Mar 31, 2025 | -240,000.00 |
| Dec 31, 2024 | 437,000.00 |
| Dec 31, 2024 | 437,000.00 |